Tim Higenbottam is a recognized expert in Respiratory Medicine, including asthma, and has extensive experience in clinical development and regulatory affairs from within the pharmaceutical industry and academia. He was Professor of Medicine at Sheffield University from 1995 and 2001. At Chiesi Farmaceutici, he was Director of Corporate Clinical Development and achieved market approvals for the NEXThaler® DPI for Asthma and FOSTAIR® for COPD. Professor Higenbottam previously held senior positions with AstraZeneca.
This person is not in the org chart